TABLE 4.
Soy protein + isoflavones (n = 25) | Soy protein + placebo (n = 24) | Control protein + isoflavones (n = 26) | Control protein + placebo (n = 22) | P (ANOVA) | |
Nutrient intake | |||||
Protein (g/d) | |||||
Food sources | 65.3 ± 2.21 | 65.3 ± 2.4 | 65.0 ± 3.2 | 67.9 ± 2.9 | 0.87 |
Supplement | 15.1 ± 0.5 | 14.5 ± 0.8 | 13.9 ± 0.8 | 13.6 ± 0.7 | 0.46 |
Total | 80.4 ± 2.3 | 79.8 ± 2.7 | 78.9 ± 3.6 | 81.5 ± 3.0 | 0.94 |
Calcium (mmol/d) | |||||
Food sources | 20.6 ± 1.5 | 21.3 ± 1.5 | 20.4 ± 1.5 | 21.0 ± 1.0 | 0.96 |
Supplement | 14.4 ± 1.3 | 12.0 ± 1.2 | 13.4 ± 1.4 | 12.1 ± 0.8 | 0.48 |
Total | 35.0 ± 1.2 | 33.3 ± 1.4 | 34.0 ± 1.4 | 33.1 ± 1.0 | 0.72 |
Vitamin D (IU) | |||||
Food sources | 137 ± 13 | 143 ± 20 | 157 ± 19 | 161 ± 15 | 0.71 |
Supplement | 366 ± 34 | 305 ± 32 | 340 ± 35 | 308 ± 21 | 0.48 |
Total | 503 ± 27 | 448 ± 36 | 502 ± 32 | 469 ± 26 | 0.52 |
Energy (MJ)2 | 6.08 ± 0.22 | 6.52 ± 0.24 | 6.30 ± 0.27 | 6.32 ± 0.27 | 0.66 |
Serum isoflavones (μmol/L) | |||||
Daidzein | 1.18 ± 0.23 | 0.21 ± 0.11 | 0.87 ± 0.17 | 0.13 ± 0.13 | 0.01 |
Genistein | 0.90 ± 0.20 | 0.03 ± 0.02 | 0.88 ± 0.18 | 0.01 ± 0.04 | 0.01 |
Equol from producers (n = 25) | 0.145 ± 0.046 | — | 0.191 ± 0.061 | — | 0.72 |
Endometrial thickness (mm) | 3.38 ± 0.32 | 4.00 ± 0.54 | 2.88 ± 0.21 | 3.19 ± 0.33 | 0.16 |
No. of observations >6 | 0 | 1 | 0 | 0 | |
Endometrial thickness change (mm) | 0.41 ± 0.22 | 0.86 ± 0.54 | 0.06 ± 0.23 | −0.16 ± 0.43 | 0.24 |
No. of observations | 16 | 11 | 17 | 13 |
Mean ± SD (all such values).
Energy from food sources only, not supplement.